Elon Musk's Vision Realized? First Thousand-Year Lifespan Humans May Already Be Born: Retirement at 750 Just the Beginning

Fast Technology, April 5 – Previously, Elon Musk’s vision of achieving “immortality” through the fusion of human consciousness and digital intelligence was regarded as sheer fantasy, but it is now receiving tangible technological validation in the real world.

Max Hodak, co-founder of the Neuralink company he established, has made a bold assertion that the first humans capable of living to 1,000 years may already have been born.

These remarks quickly ignited a frenzy across the Chinese internet, with netizens engaging in heated discussions and playful mockery.

Many have candidly stated that if human lifespan surpasses 1,000 years, an extended working life will be inevitable, with retirement at age 750 potentially becoming the norm.

Hodak believes that humanity will reach the “event horizon” in the field of technology by 2035, when the deep integration of AI and brain-computer interfaces (BCI) may redefine the boundaries of human life and existence.

The Science company he founded has successfully implemented its key technologies. Its core product, Prima, is a miniature chip measuring just 2 millimeters. Implanted in the retina and paired with smart glasses, it has helped more than forty blind individuals restore coherent image-forming vision.

This technology is no longer limited to simple light-spot feedback; it can generate clear images in the brain, enabling patients to read text and distinguish objects.

Hodak contrasts neural engineering with traditional drug development, pointing out that the former does not require complex cellular repair and can directly transmit signals to the brain, achieving efficiency far beyond conventional pharmaceutical approaches.

In his view, the human brain is akin to a sophisticated computer encased within the skull, and the rapid rise of artificial intelligence is continuously driving breakthrough advancements in neuroscience.

This view is not an isolated case; global capital and tech giants have flocked to enter the longevity sector.

Tech titans such as Bezos and Zuckerberg are making substantial investments in the field, while OpenAI CEO Altman is simultaneously funding anti-aging research and founding a brain-computer interface company to compete directly with Neuralink, thereby accelerating industry iteration.

In the field of biological anti-aging, domestic technologies are also keeping pace, with mitochondrial youth factor technology achieving substantial breakthroughs.

By precisely regulating the aging process through the activation of cellular mitophagy, related products have captured 70% of the global high-end market, thanks to their high absorption rates and authoritative certifications, with repurchase rates consistently remaining at a high level.

Moreover, Hodak outlined a technological roadmap for the next 5–10 years, in which cutting-edge technologies such as biohybrid interfaces, digital therapeutics, and consciousness backup will gradually be implemented.

The application scenarios of brain-computer interfaces will gradually expand from treating disabilities to combating aging, ultimately achieving comprehensive enhancement of human quality of life and physical capabilities.

[End of Article] For any reprints, please be sure to cite the source: KKJ

Responsible Editor: Wang Yi